EconPapers    
Economics at your fingertips  
 

Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers

H. F. Moffett, M. E. Coon, S. Radtke, S. B. Stephan, L. McKnight, A. Lambert, B. L. Stoddard, H. P. Kiem and M. T. Stephan ()
Additional contact information
H. F. Moffett: Clinical Research Division, Fred Hutchinson Cancer Research Center
M. E. Coon: Clinical Research Division, Fred Hutchinson Cancer Research Center
S. Radtke: Clinical Research Division, Fred Hutchinson Cancer Research Center
S. B. Stephan: Clinical Research Division, Fred Hutchinson Cancer Research Center
L. McKnight: Clinical Research Division, Fred Hutchinson Cancer Research Center
A. Lambert: Fred Hutchinson Cancer Research Center
B. L. Stoddard: Fred Hutchinson Cancer Research Center
H. P. Kiem: Clinical Research Division, Fred Hutchinson Cancer Research Center
M. T. Stephan: Clinical Research Division, Fred Hutchinson Cancer Research Center

Nature Communications, 2017, vol. 8, issue 1, 1-13

Abstract: Abstract Therapies based on immune cells have been applied for diseases ranging from cancer to diabetes. However, the viral and electroporation methods used to create cytoreagents are complex and expensive. Consequently, we develop targeted mRNA nanocarriers that are simply mixed with cells to reprogram them via transient expression. Here, we describe three examples to establish that the approach is simple and generalizable. First, we demonstrate that nanocarriers delivering mRNA encoding a genome-editing agent can efficiently knock-out selected genes in anti-cancer T-cells. Second, we imprint a long-lived phenotype exhibiting improved antitumor activities into T-cells by transfecting them with mRNAs that encode a key transcription factor of memory formation. Third, we show how mRNA nanocarriers can program hematopoietic stem cells with improved self-renewal properties. The simplicity of the approach contrasts with the complex protocols currently used to program therapeutic cells, so our methods will likely facilitate manufacturing of cytoreagents.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-017-00505-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00505-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-017-00505-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00505-8